id	sid	eid	entity	type
eshs-4388	1	1	2690-3679	CARDINAL
eshs-4388	1	2	issn 2690-3687	PERSON
eshs-4388	2	1	3	CARDINAL
eshs-4388	2	2	1	CARDINAL
eshs-4388	2	3	2022	CARDINAL
eshs-4388	2	4	9	CARDINAL
eshs-4388	2	5	sahu seema1	PERSON
eshs-4388	2	6	shah gulab chand2	PERSON
eshs-4388	2	7	manigauha ashish1	PERSON
eshs-4388	2	8	1	CARDINAL
eshs-4388	2	9	karond	GPE
eshs-4388	2	10	2	CARDINAL
eshs-4388	2	11	462033	DATE
eshs-4388	3	1	sahu seema	PERSON
eshs-4388	3	2	mittal institute	ORG
eshs-4388	3	3	karond	GPE
eshs-4388	3	4	december 22, 2020	DATE
eshs-4388	3	5	january 14	DATE
eshs-4388	3	6	2021	CARDINAL
eshs-4388	3	7	december 14	DATE
eshs-4388	3	8	2021	CARDINAL
eshs-4388	3	9	http://dx.doi.org/10.22158/eshs.v3n1p9	ORG
eshs-4388	10	1	tga	ORG
eshs-4388	10	2	www.scholink.org/ojs/index.php/eshs	DATE
eshs-4388	11	1	3	CARDINAL
eshs-4388	11	2	1	CARDINAL
eshs-4388	11	3	2022 10	DATE
eshs-4388	11	4	scholink inc	ORG
eshs-4388	11	5	1	CARDINAL
eshs-4388	15	1	the national eye institute	ORG
eshs-4388	15	2	several millions	CARDINAL
eshs-4388	15	3	the age of forty	DATE
eshs-4388	15	4	one	CARDINAL
eshs-4388	16	1	age forty	DATE
eshs-4388	16	2	2010	DATE
eshs-4388	16	3	u.s.	GPE
eshs-4388	16	4	142,648,393	CARDINAL
eshs-4388	16	5	36,883,997	CARDINAL
eshs-4388	16	6	2016	DATE
eshs-4388	17	1	approximately over a quarter	DATE
eshs-4388	17	2	25.9%	PERCENT
eshs-4388	17	3	age forty	DATE
eshs-4388	18	1	1	CARDINAL
eshs-4388	18	2	1	CARDINAL
eshs-4388	18	3	2010	DATE
eshs-4388	19	1	u.s.	GPE
eshs-4388	19	2	national eye institute	ORG
eshs-4388	21	1	https://nei.nih.gov/eyedata/vision_impaired#1	PERSON
eshs-4388	22	1	march 27, 2020	DATE
eshs-4388	22	2	ten years	DATE
eshs-4388	22	3	the year 2000	DATE
eshs-4388	22	4	almost 130%	PERCENT
eshs-4388	22	5	2016	DATE
eshs-4388	23	1	each subsequent year	DATE
eshs-4388	23	2	the year 2030	DATE
eshs-4388	23	3	two-fold	CARDINAL
eshs-4388	23	4	2010	DATE
eshs-4388	23	5	2050	DATE
eshs-4388	23	6	more than a 3-fold	CARDINAL
eshs-4388	23	7	1	CARDINAL
eshs-4388	23	8	2	CARDINAL
eshs-4388	23	9	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	24	1	3	CARDINAL
eshs-4388	24	2	1	CARDINAL
eshs-4388	24	3	2022 11	DATE
eshs-4388	24	4	scholink inc.	ORG
eshs-4388	24	5	1	CARDINAL
eshs-4388	24	6	2010-2030-2050) year	DATE
eshs-4388	24	7	hispanic	NORP
eshs-4388	24	8	2010	DATE
eshs-4388	25	1	3,398,977	CARDINAL
eshs-4388	25	2	7,169,680	CARDINAL
eshs-4388	25	3	9,019,189	CARDINAL
eshs-4388	25	4	2,000,853 958,842	CARDINAL
eshs-4388	25	5	142,648393 103,846,437	DATE
eshs-4388	25	6	14,901,369	CARDINAL
eshs-4388	25	7	8,709,810	CARDINAL
eshs-4388	25	8	national eye institute	ORG
eshs-4388	28	1	march 27, 2020	DATE
eshs-4388	29	1	2	CARDINAL
eshs-4388	29	2	2010-2030-2050	DATE
eshs-4388	29	3	national eye institute	ORG
eshs-4388	31	1	https://nei.nih.gov/eyedata/vision_impaired#1	PERSON
eshs-4388	32	1	march 27, 2020	DATE
eshs-4388	32	2	ros	CARDINAL
eshs-4388	33	1	every day	DATE
eshs-4388	33	2	2015	DATE
eshs-4388	34	1	nci	ORG
eshs-4388	34	2	2014	DATE
eshs-4388	36	1	atp	ORG
eshs-4388	36	2	90%	PERCENT
eshs-4388	37	1	2017	CARDINAL
eshs-4388	38	1	2015	DATE
eshs-4388	40	1	3	CARDINAL
eshs-4388	40	2	1	CARDINAL
eshs-4388	40	3	2022 12	CARDINAL
eshs-4388	40	4	scholink inc.	ORG
eshs-4388	45	1	a person ages	DATE
eshs-4388	50	1	nci	ORG
eshs-4388	50	2	2014	DATE
eshs-4388	51	1	coenzyme q10	ORG
eshs-4388	51	2	ros	CARDINAL
eshs-4388	51	3	harvard	ORG
eshs-4388	51	4	2017	DATE
eshs-4388	54	1	2	CARDINAL
eshs-4388	54	2	2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one	QUANTITY
eshs-4388	54	3	bioflavonoid	ORG
eshs-4388	54	4	3hydroxyflavone	CARDINAL
eshs-4388	54	5	3	CARDINAL
eshs-4388	54	6	kelly, 2011	ORG
eshs-4388	55	1	3	CARDINAL
eshs-4388	56	1	3	CARDINAL
eshs-4388	56	2	1	CARDINAL
eshs-4388	56	3	2022 13	DATE
eshs-4388	56	4	scholink inc.	ORG
eshs-4388	60	1	one	CARDINAL
eshs-4388	60	2	3	CARDINAL
eshs-4388	60	3	6	CARDINAL
eshs-4388	61	1	3	CARDINAL
eshs-4388	64	1	3	CARDINAL
eshs-4388	65	1	glycerol monostearate	PERSON
eshs-4388	65	2	ato 888®	ORG
eshs-4388	66	1	miglyol	PERSON
eshs-4388	66	2	dr reddy	PERSON
eshs-4388	66	3	hyderabad india	LOC
eshs-4388	67	1	80	DATE
eshs-4388	67	2	acros organic	ORG
eshs-4388	68	1	188	CARDINAL
eshs-4388	70	1	fisher	ORG
eshs-4388	71	1	pel-freez biologics	ORG
eshs-4388	73	1	4	CARDINAL
eshs-4388	74	1	0.7%	PERCENT
eshs-4388	74	2	1.3%	PERCENT
eshs-4388	74	3	ato 888®	ORG
eshs-4388	75	1	100	CARDINAL
eshs-4388	75	2	2.25%	PERCENT
eshs-4388	77	1	0.75%	PERCENT
eshs-4388	77	2	80	CARDINAL
eshs-4388	77	3	188	CARDINAL
eshs-4388	78	1	600	CARDINAL
eshs-4388	78	2	2 minutes	TIME
eshs-4388	79	1	0.1%	PERCENT
eshs-4388	79	2	16,000	CARDINAL
eshs-4388	79	3	3 minutes	TIME
eshs-4388	80	1	15-second	TIME
eshs-4388	80	2	3 minutes	TIME
eshs-4388	83	1	0.7%	PERCENT
eshs-4388	83	2	812	CARDINAL
eshs-4388	83	3	1.3%	PERCENT
eshs-4388	83	4	ato 888®	ORG
eshs-4388	84	1	100	CARDINAL
eshs-4388	84	2	2.25%	PERCENT
eshs-4388	87	1	3	CARDINAL
eshs-4388	87	2	1	CARDINAL
eshs-4388	87	3	2022 14	DATE
eshs-4388	87	4	scholink inc.	ORG
eshs-4388	87	5	0.75%	PERCENT
eshs-4388	87	6	80	CARDINAL
eshs-4388	87	7	188	CARDINAL
eshs-4388	88	1	600	CARDINAL
eshs-4388	88	2	2 minutes	TIME
eshs-4388	89	1	0.1%	PERCENT
eshs-4388	89	2	16,000	CARDINAL
eshs-4388	89	3	3 minutes	TIME
eshs-4388	89	4	15-second	TIME
eshs-4388	89	5	3 minutes	TIME
eshs-4388	94	1	10%	PERCENT
eshs-4388	94	2	10 mm	QUANTITY
eshs-4388	94	3	75°	QUANTITY
eshs-4388	94	4	at least one minute	TIME
eshs-4388	95	1	a few seconds	TIME
eshs-4388	96	1	an additional minute	TIME
eshs-4388	97	1	approximately 8 mg	QUANTITY
eshs-4388	98	1	d.	NORP
eshs-4388	98	2	40:60	PERSON
eshs-4388	99	1	a 1 mg/ml	QUANTITY
eshs-4388	100	1	1 μg	CARDINAL
eshs-4388	100	2	2	CARDINAL
eshs-4388	100	3	5	CARDINAL
eshs-4388	100	4	10	CARDINAL
eshs-4388	100	5	20	CARDINAL
eshs-4388	101	1	369	CARDINAL
eshs-4388	102	1	sln	ORG
eshs-4388	102	2	nlc	ORG
eshs-4388	102	3	500	CARDINAL
eshs-4388	104	1	500	CARDINAL
eshs-4388	104	2	15 minutes	TIME
eshs-4388	105	1	100	CARDINAL
eshs-4388	108	1	100	CARDINAL
eshs-4388	108	2	10 minutes	TIME
eshs-4388	109	1	15 minutes	TIME
eshs-4388	110	1	100	CARDINAL
eshs-4388	111	1	5 μm evo	QUANTITY
eshs-4388	111	2	100	CARDINAL
eshs-4388	111	3	250	CARDINAL
eshs-4388	111	4	4.6 mm	QUANTITY
eshs-4388	112	1	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	113	1	3	CARDINAL
eshs-4388	113	2	1	CARDINAL
eshs-4388	113	3	2022 15	CARDINAL
eshs-4388	113	4	scholink inc	ORG
eshs-4388	113	5	e. characterization	PERSON
eshs-4388	113	6	40:60	PERSON
eshs-4388	114	1	a 1 mg/ml	QUANTITY
eshs-4388	115	1	1 μg	CARDINAL
eshs-4388	115	2	2	CARDINAL
eshs-4388	115	3	5	CARDINAL
eshs-4388	115	4	10	CARDINAL
eshs-4388	115	5	20	CARDINAL
eshs-4388	116	1	369	CARDINAL
eshs-4388	117	1	approximately 8 mg	TIME
eshs-4388	117	2	2 ml	QUANTITY
eshs-4388	118	1	5 minutes	TIME
eshs-4388	119	1	20	CARDINAL
eshs-4388	120	1	369	CARDINAL
eshs-4388	121	1	10,000	CARDINAL
eshs-4388	121	2	dalton mwco	PERSON
eshs-4388	122	1	5%	PERCENT
eshs-4388	124	1	18 ml	QUANTITY
eshs-4388	124	2	1 ml	QUANTITY
eshs-4388	125	1	15, 30,	DATE
eshs-4388	125	2	60	DATE
eshs-4388	125	3	90	DATE
eshs-4388	125	4	120	CARDINAL
eshs-4388	125	5	150	CARDINAL
eshs-4388	125	6	180-minute	TIME
eshs-4388	125	7	1 ml	QUANTITY
eshs-4388	125	8	1 ml	QUANTITY
eshs-4388	127	1	34°	QUANTITY
eshs-4388	128	1	5%	PERCENT
eshs-4388	129	1	por®	ORG
eshs-4388	129	2	10,000 daltons mwco	QUANTITY
eshs-4388	129	3	30 minutes	TIME
eshs-4388	130	1	por®	ORG
eshs-4388	131	1	approximately 45 mg	QUANTITY
eshs-4388	132	1	por®	ORG
eshs-4388	132	2	por®	ORG
eshs-4388	132	3	4	CARDINAL
eshs-4388	133	1	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	134	1	3	CARDINAL
eshs-4388	134	2	1	CARDINAL
eshs-4388	134	3	2022 16	CARDINAL
eshs-4388	134	4	scholink inc.	ORG
eshs-4388	134	5	4	CARDINAL
eshs-4388	134	6	adelli gr	PERSON
eshs-4388	134	7	hingorani t	PERSON
eshs-4388	136	1	european journal of pharmaceutics	ORG
eshs-4388	136	2	2015	CARDINAL
eshs-4388	136	3	92:74-82	DATE
eshs-4388	136	4	3.2 ml	QUANTITY
eshs-4388	137	1	nlc	ORG
eshs-4388	137	2	3 mg	QUANTITY
eshs-4388	137	3	3.2 ml	QUANTITY
eshs-4388	137	4	3.2 ml	QUANTITY
eshs-4388	138	1	30	CARDINAL
eshs-4388	138	2	60	DATE
eshs-4388	138	3	90	DATE
eshs-4388	138	4	120	CARDINAL
eshs-4388	138	5	150	CARDINAL
eshs-4388	138	6	180-minute	TIME
eshs-4388	139	1	0.6 ml	QUANTITY
eshs-4388	139	2	0.6 ml	QUANTITY
eshs-4388	140	1	369	CARDINAL
eshs-4388	141	1	5	CARDINAL
eshs-4388	141	2	5.1	CARDINAL
eshs-4388	141	3	65.4	CARDINAL
eshs-4388	141	4	0.29	CARDINAL
eshs-4388	141	5	78.4 ± 1.6%	MONEY
eshs-4388	141	6	90.9 ± 0.3%	MONEY
eshs-4388	142	1	por®	ORG
eshs-4388	142	2	33.3 ± 1.5%	PERCENT
eshs-4388	143	1	2	CARDINAL
eshs-4388	143	2	5	CARDINAL
eshs-4388	143	3	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	144	1	3	CARDINAL
eshs-4388	144	2	1	CARDINAL
eshs-4388	144	3	2022 17	DATE
eshs-4388	144	4	scholink inc.	ORG
eshs-4388	144	5	2	CARDINAL
eshs-4388	144	6	65.4	CARDINAL
eshs-4388	144	7	0.29	CARDINAL
eshs-4388	144	8	90.9±0.3 %	PERCENT
eshs-4388	144	9	por®	ORG
eshs-4388	144	10	33.3±1.5	CARDINAL
eshs-4388	144	11	5	CARDINAL
eshs-4388	144	12	46.1	CARDINAL
eshs-4388	144	13	0.18	CARDINAL
eshs-4388	144	14	86.6 ± 0.2%	PERCENT
eshs-4388	144	15	93.4 ± 0.1%	PERCENT
eshs-4388	145	1	por®	ORG
eshs-4388	145	2	47.1 ± 7.9%	PERCENT
eshs-4388	146	1	3	CARDINAL
eshs-4388	146	2	6	CARDINAL
eshs-4388	147	1	sln	ORG
eshs-4388	147	2	nlc	ORG
eshs-4388	147	3	7	CARDINAL
eshs-4388	147	4	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	148	1	3	CARDINAL
eshs-4388	148	2	1	CARDINAL
eshs-4388	148	3	2022 18	DATE
eshs-4388	148	4	scholink inc.	ORG
eshs-4388	148	5	3	CARDINAL
eshs-4388	148	6	nlc	ORG
eshs-4388	148	7	46.1	CARDINAL
eshs-4388	148	8	0.18	CARDINAL
eshs-4388	148	9	86.6±0.2	ORG
eshs-4388	148	10	93.4±0.1 %	PERCENT
eshs-4388	148	11	por®	ORG
eshs-4388	148	12	6	CARDINAL
eshs-4388	149	1	nlc	ORG
eshs-4388	150	1	3	CARDINAL
eshs-4388	150	2	1	CARDINAL
eshs-4388	150	3	2022 19	DATE
eshs-4388	150	4	scholink inc.	ORG
eshs-4388	150	5	7	CARDINAL
eshs-4388	150	6	sln	ORG
eshs-4388	150	7	nlc	ORG
eshs-4388	150	8	76.3 ± 4.1%	PERCENT
eshs-4388	152	1	por®	ORG
eshs-4388	153	1	5.2	CARDINAL
eshs-4388	153	2	369	CARDINAL
eshs-4388	153	3	0.9989	CARDINAL
eshs-4388	154	1	tga	ORG
eshs-4388	155	1	8	CARDINAL
eshs-4388	155	2	10	CARDINAL
eshs-4388	156	1	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	157	1	3	CARDINAL
eshs-4388	157	2	1	CARDINAL
eshs-4388	157	3	2022 20	CARDINAL
eshs-4388	157	4	scholink inc.	ORG
eshs-4388	157	5	8	CARDINAL
eshs-4388	158	1	9	CARDINAL
eshs-4388	159	1	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	160	1	3	CARDINAL
eshs-4388	160	2	1	CARDINAL
eshs-4388	160	3	2022 21	DATE
eshs-4388	160	4	scholink inc.	ORG
eshs-4388	160	5	10	CARDINAL
eshs-4388	161	1	4	CARDINAL
eshs-4388	161	2	11	CARDINAL
eshs-4388	161	3	0.636 cm	QUANTITY
eshs-4388	161	4	0.026 ± 0.002	MONEY
eshs-4388	161	5	0.036 ± 0.006	MONEY
eshs-4388	161	6	0.144 ± 0.009	MONEY
eshs-4388	163	1	4	CARDINAL
eshs-4388	163	2	106	CARDINAL
eshs-4388	164	1	0.135±0.012	CARDINAL
eshs-4388	164	2	0.747±0.047	DATE
eshs-4388	165	1	3	CARDINAL
eshs-4388	165	2	1	CARDINAL
eshs-4388	165	3	2022 22	CARDINAL
eshs-4388	165	4	scholink inc.	ORG
eshs-4388	165	5	11	CARDINAL
eshs-4388	168	1	500	CARDINAL
eshs-4388	169	1	nlc	ORG
eshs-4388	170	1	close to zero	CARDINAL
eshs-4388	171	1	between -10 and -20 mv	QUANTITY
eshs-4388	172	1	at least 90%	PERCENT
eshs-4388	173	1	por®	ORG
eshs-4388	173	2	30-50%	PERCENT
eshs-4388	174	1	three	CARDINAL
eshs-4388	174	2	2%	PERCENT
eshs-4388	174	3	about 8%	PERCENT
eshs-4388	174	4	two	CARDINAL
eshs-4388	175	1	nlc	ORG
eshs-4388	181	1	3	CARDINAL
eshs-4388	181	2	1	CARDINAL
eshs-4388	181	3	2022 23	CARDINAL
eshs-4388	181	4	scholink inc.	ORG
eshs-4388	183	1	12	CARDINAL
eshs-4388	183	2	nlc	ORG
eshs-4388	184	1	12	CARDINAL
eshs-4388	185	1	nlc	ORG
eshs-4388	185	2	beloqui	PERSON
eshs-4388	185	3	solinis ma	PERSON
eshs-4388	185	4	almeida aj	PERSON
eshs-4388	186	1	nanomedicine	PERSON
eshs-4388	186	2	2016	CARDINAL
eshs-4388	186	3	12:143-161	CARDINAL
eshs-4388	186	4	nlc	ORG
eshs-4388	187	1	three	CARDINAL
eshs-4388	189	1	7-14x	DATE
eshs-4388	189	2	two	CARDINAL
eshs-4388	190	1	0.636 cm	QUANTITY
eshs-4388	191	1	4-5x	CARDINAL
eshs-4388	192	1	www.scholink.org/ojs/index.php/eshs education	PERSON
eshs-4388	193	1	3	CARDINAL
eshs-4388	193	2	1	CARDINAL
eshs-4388	193	3	scholink inc.	ORG
eshs-4388	193	4	two	CARDINAL
eshs-4388	194	1	as centimeters per second	QUANTITY
eshs-4388	195	1	two	CARDINAL
eshs-4388	196	1	second	ORDINAL
eshs-4388	196	2	4-6x	CARDINAL
eshs-4388	198	1	nlc	ORG
eshs-4388	199	1	abraham	PERSON
eshs-4388	199	2	m., & acree	ORG
eshs-4388	199	3	w.	PERSON
eshs-4388	199	4	2014	DATE
eshs-4388	201	1	197	CARDINAL
eshs-4388	201	2	157	CARDINAL
eshs-4388	202	1	adelli	PERSON
eshs-4388	202	2	g. r.	PERSON
eshs-4388	202	3	balguri	GPE
eshs-4388	202	4	s., & majumdar	ORG
eshs-4388	202	5	s.	PERSON
eshs-4388	202	6	2015	CARDINAL
eshs-4388	204	1	pharmscitech	PERSON
eshs-4388	204	2	16	CARDINAL
eshs-4388	204	3	1220	CARDINAL
eshs-4388	205	1	adelli	PERSON
eshs-4388	205	2	g. r.	PERSON
eshs-4388	205	3	hingorani	ORG
eshs-4388	205	4	t., & punyamurthula	ORG
eshs-4388	205	5	2015	DATE
eshs-4388	207	1	european journal of pharmaceutics	ORG
eshs-4388	207	2	biopharmaceutics	ORG
eshs-4388	207	3	92	CARDINAL
eshs-4388	207	4	74	CARDINAL
eshs-4388	208	1	n. p.	PERSON
eshs-4388	208	2	macedo	PERSON
eshs-4388	208	3	a. s.	PERSON
eshs-4388	208	4	s.	PERSON
eshs-4388	208	5	2014	DATE
eshs-4388	209	1	nlc	ORG
eshs-4388	210	1	lwt	ORG
eshs-4388	210	2	59	CARDINAL
eshs-4388	210	3	115	CARDINAL
eshs-4388	211	1	balguri	GPE
eshs-4388	211	2	s. p.	PERSON
eshs-4388	211	3	adelli	PERSON
eshs-4388	211	4	g. r., & majumdar	PERSON
eshs-4388	211	5	s.	PERSON
eshs-4388	211	6	2016	DATE
eshs-4388	212	1	sln	NORP
eshs-4388	212	2	nlc	ORG
eshs-4388	213	1	european journal of pharmaceutics	ORG
eshs-4388	213	2	biopharmaceutics	ORG
eshs-4388	213	3	109	CARDINAL
eshs-4388	213	4	224	CARDINAL
eshs-4388	214	1	beloqui	PERSON
eshs-4388	214	2	a., solinis	PERSON
eshs-4388	214	3	m. a.	PERSON
eshs-4388	214	4	rodríguez-gascón	ORG
eshs-4388	214	5	a.	PERSON
eshs-4388	214	6	almeida	PERSON
eshs-4388	214	7	a. j., & préat	PERSON
eshs-4388	214	8	2016	CARDINAL
eshs-4388	216	1	nanomedicine	PERSON
eshs-4388	216	2	12	CARDINAL
eshs-4388	216	3	143	CARDINAL
eshs-4388	217	1	a. b.	PERSON
eshs-4388	217	2	2009	DATE
eshs-4388	220	1	crowley	PERSON
eshs-4388	220	2	feng	PERSON
eshs-4388	220	3	2007	DATE
eshs-4388	221	1	i. drug development & industrial pharmacy	ORG
eshs-4388	221	2	33(9	CARDINAL
eshs-4388	221	3	909-926	CARDINAL
eshs-4388	222	1	ipswich	GPE
eshs-4388	222	2	ma	GPE
eshs-4388	222	3	dan	PERSON
eshs-4388	222	4	2016	DATE
eshs-4388	224	1	171	CARDINAL
eshs-4388	224	2	37	CARDINAL
eshs-4388	225	1	dhawan, s.	PERSON
eshs-4388	225	2	kapil	PERSON
eshs-4388	225	3	r., & singh	ORG
eshs-4388	225	4	2011	DATE
eshs-4388	228	1	3	CARDINAL
eshs-4388	228	2	1	CARDINAL
eshs-4388	228	3	2022 25	DATE
eshs-4388	228	4	scholink inc.	ORG
eshs-4388	228	5	63	DATE
eshs-4388	228	6	342	CARDINAL
eshs-4388	229	1	douroumis	ORG
eshs-4388	229	2	2012	DATE
eshs-4388	231	1	oxford	NORP
eshs-4388	231	2	john wiley & sons	ORG
eshs-4388	232	1	s. d.	PERSON
eshs-4388	232	2	2015	CARDINAL
eshs-4388	234	1	university of maryland medical center	ORG
eshs-4388	235	1	march 27, 2017	DATE
eshs-4388	236	1	2017	CARDINAL
eshs-4388	238	1	march 27, 2017	DATE
eshs-4388	238	2	r.	NORP
eshs-4388	238	3	h. k.	PERSON
eshs-4388	238	4	a., & mitra	ORG
eshs-4388	238	5	k.	PERSON
eshs-4388	238	6	2010	DATE
eshs-4388	240	1	348-360	CARDINAL
eshs-4388	241	1	harvard	ORG
eshs-4388	241	2	t. h.	GPE
eshs-4388	241	3	2017	CARDINAL
eshs-4388	242	1	chan	PERSON
eshs-4388	244	1	march 27, 2017	DATE
eshs-4388	244	2	z.	PERSON
eshs-4388	244	3	f., & wan	ORG
eshs-4388	244	4	2012	DATE
eshs-4388	245	1	drosera peltata smith var	ORG
eshs-4388	246	1	glabrata y.z.ruan	PERSON
eshs-4388	247	1	pharmacognosy magazine	ORG
eshs-4388	247	2	8(32	CARDINAL
eshs-4388	247	3	263	CARDINAL
eshs-4388	248	1	hippalgaonkar	PERSON
eshs-4388	248	2	k.	PERSON
eshs-4388	248	3	adelli	PERSON
eshs-4388	248	4	g. r.	PERSON
eshs-4388	248	5	k.	PERSON
eshs-4388	248	6	2013	DATE
eshs-4388	250	1	29(2	CARDINAL
eshs-4388	250	2	216	CARDINAL
eshs-4388	251	1	kaufman	ORG
eshs-4388	251	2	p. l.	PERSON
eshs-4388	251	3	alm, a., & levin	PERSON
eshs-4388	251	4	l. a.	PERSON
eshs-4388	251	5	2011	DATE
eshs-4388	252	1	adler	PERSON
eshs-4388	253	1	philadelphia	GPE
eshs-4388	253	2	saunders	ORG
eshs-4388	254	1	kelly	PERSON
eshs-4388	254	2	g. s.	PERSON
eshs-4388	254	3	2011	DATE
eshs-4388	256	1	16	CARDINAL
eshs-4388	256	2	172	CARDINAL
eshs-4388	257	1	kumari	PERSON
eshs-4388	257	2	s. k., & pakade	PERSON
eshs-4388	257	3	2010	DATE
eshs-4388	259	1	colloids	PERSON
eshs-4388	259	2	biointerfaces	PERSON
eshs-4388	259	3	80	DATE
eshs-4388	259	4	184	CARDINAL
eshs-4388	260	1	mehnert	PERSON
eshs-4388	260	2	w., & mäder	ORG
eshs-4388	260	3	2012	DATE
eshs-4388	262	1	64	DATE
eshs-4388	262	2	83	CARDINAL
eshs-4388	264	1	2017	CARDINAL
eshs-4388	266	1	march 27, 2017	DATE
eshs-4388	266	2	https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet national eye institute	ORG
eshs-4388	267	1	2017	CARDINAL
eshs-4388	269	1	march 27, 2017	DATE
eshs-4388	269	2	https://nei.nih.gov/eyedata/ vision_impaired#1 national eye institute	ORG
eshs-4388	270	1	2017	CARDINAL
eshs-4388	271	1	america	GPE
eshs-4388	272	1	march 27, 2017	DATE
eshs-4388	272	2	https://nei.nih.gov/eyedata/adultvision_usa national eye institute	ORG
eshs-4388	273	1	2017	CARDINAL
eshs-4388	275	1	march 27, 2017	DATE
eshs-4388	275	2	m. c.	PERSON
eshs-4388	275	3	aung	GPE
eshs-4388	275	4	m. h., & hanif	ORG
eshs-4388	275	5	a. m.	PERSON
eshs-4388	275	6	2015	DATE
eshs-4388	277	1	5862-5870	DATE
eshs-4388	278	1	ab120247	ORG
eshs-4388	279	1	2017	CARDINAL
eshs-4388	280	1	abcam	PERSON
eshs-4388	281	1	march 27, 2017	DATE
eshs-4388	281	2	http://www.abcam.com/quercetin-ab120247.html	ORG
eshs-4388	282	1	3	CARDINAL
eshs-4388	282	2	1	CARDINAL
eshs-4388	282	3	2022 26	CARDINAL
eshs-4388	282	4	scholink inc.	ORG
eshs-4388	284	1	2016	CARDINAL
eshs-4388	285	1	ann arbor	PERSON
eshs-4388	285	2	mi:	PERSON
eshs-4388	285	3	cayman chemical company	ORG
eshs-4388	286	1	repka	ORG
eshs-4388	286	2	m. a.	PERSON
eshs-4388	286	3	battu	ORG
eshs-4388	286	4	s. k., & upadhye	PERSON
eshs-4388	286	5	s. b.	PERSON
eshs-4388	286	6	2007	DATE
eshs-4388	287	1	drug development & industrial pharmacy	ORG
eshs-4388	287	2	33(10),1043-1057	DATE
eshs-4388	288	1	r., & patil	ORG
eshs-4388	288	2	s. j. (	PERSON
eshs-4388	288	3	n.d.	GPE
eshs-4388	290	1	1	CARDINAL
eshs-4388	291	1	srirangam	GPE
eshs-4388	291	2	r.	NORP
eshs-4388	291	3	hippalgaonkar	PERSON
eshs-4388	291	4	k.	PERSON
eshs-4388	291	5	b.	GPE
eshs-4388	291	6	khan	GPE
eshs-4388	291	7	i., & majumdar	ORG
eshs-4388	291	8	s.	PERSON
eshs-4388	291	9	2012	DATE
eshs-4388	292	1	hesperetin	ORG
eshs-4388	293	1	28(6	CARDINAL
eshs-4388	293	2	618-627	CARDINAL
eshs-4388	294	1	united mitochondrial disease foundation	ORG
eshs-4388	295	1	2017	CARDINAL
eshs-4388	297	1	march 27, 2017	DATE
eshs-4388	297	2	2012	DATE
eshs-4388	299	1	357	CARDINAL
eshs-4388	300	1	croatia	GPE
eshs-4388	300	2	intech	ORG
eshs-4388	301	1	wu	PERSON
eshs-4388	301	2	t. h.	GPE
eshs-4388	301	3	f. l.	PERSON
eshs-4388	301	4	& lin	PERSON
eshs-4388	301	5	l.t.	PERSON
eshs-4388	301	6	2008	DATE
eshs-4388	303	1	international journal of pharmaceutics	ORG
eshs-4388	303	2	346	CARDINAL
eshs-4388	303	3	160	CARDINAL